Skip to content
Ophthalmic Solution Allopathic

Contova DS 0.20% ophthalmic solution

Generic: Olopatadine Hydrochloride (Ophthalmic)

Company: Not listed yet. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength0.20%
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated September 7, 2024.

Compare

Same generic, same strength

Sorted by price per ophthalmic solution. Ask your pharmacist before you switch brands.

Olopatadine Hydrochloride (Ophthalmic) 0.20% ophthalmic solutions

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Olopatadine Hydrochloride (Ophthalmic) guide

Indications

Rhinitis Olopatadine is indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Dosage and administration

0.1% Sterile Eye Drops: One drop in each affected eye two times per day at an interval of 6 to 8 hours. 0.2% Sterile Eye Drops: One drop in the affected eye once a day. 0.7% Sterile Eye Drops: One drop in each affected eye once a day.

Side effects

Headaches have been reported at an incidence of 7%. The following adverse experiences have been reported in less than 5% of patients: Asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion

Precautions and warnings

Olopatadine HCl ophthalmic solution should not be used to treat contact lens related irritation. Patients who wear soft contact lenses should be instructed to wait at least ten minutes after instilling Olopatadine Hydrochloride ophthalmic solution before they insert their contact lenses.

Pregnancy and lactation

There are no adequate and well controlled studies in pregnant women. Because animal studies are not always predictive of human responses, this drug should be used in pregnant women only if the potential benefit to the mother justifies the potential risk to the fetus. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Olopatadine Hydrochloride ophthalmic solution is administered to a nursing mother.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250